|
|
||||||||
Clinical Chemistry, Vol 41, 1761-1767, Copyright © 1995 by American Association for Clinical Chemistry
M Nauck, K Winkler, W Marz and H Wieland
Department of Medicine, University Hospital of Freiburg, Germany.
Quantification of lipoprotein cholesterol was performed by enzymatic staining of cholesterol in a new agarose gel electrophoresis method that allows the separation of LDL, VLDL, HDL, and lipoprotein(a) [Lp(a)]. Lp(a) shows an electrophoretic mobility clearly distinct from VLDL and HDL. The total CVs of lipoprotein cholesterol varied between 2.7% and 3.9% for LDL, 7.8% and 23.2% for VLDL, 5.2% and 9.5% for HDL, and 6.8% and 16.4% for Lp(a). Comparison of LDL-, VLDL-, and HDL- cholesterol concentrations with the results of a combined ultracentrifugation and precipitation technique gave correlation coefficients of 0.961, 0.947, and 0.918, respectively; comparison of Lp(a)-cholesterol values with those of a nephelometric Lp(a) assay gave r = 0.906. The new electrophoretic assay has several advantages: It allows the quantification of Lp(a)-cholesterol; VLDL-cholesterol is not affected by Lp(a)-cholesterol; and the LDL-cholesterol fraction does not contain Lp(a)-cholesterol, as happens with LDL-cholesterol determined by ultracentrifugation and precipitation.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al. Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells J. Virol., April 1, 2008; 82(7): 3466 - 3479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Schwedler, K. Amann, K. Wernicke, A. Krebs, M. Nauck, C. Wanner, L. A. Potempa, and J. Galle Native C-Reactive Protein Increases Whereas Modified C-Reactive Protein Reduces Atherosclerosis in Apolipoprotein E-Knockout Mice Circulation, August 16, 2005; 112(7): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wanner, V. Krane, W. Marz, M. Olschewski, J. F.E. Mann, G. Ruf, E. Ritz, and the German Diabetes and Dialysis Study Investigato Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis N. Engl. J. Med., July 21, 2005; 353(3): 238 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hidaka, M. Tozuka, B. Meyer, K. Yamauchi, M. Sugano, T. Nakabayashi, and T. Katsuyama Characterization of Triglyceride Rich Lipoproteins with Very Light Density by Ultracentrifugation and Agarose Gel Electrophoresis using Triglyceride- and Cholesterol-Staining Ann. Clin. Lab. Sci., April 1, 2003; 33(2): 167 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Meinertz, K. Nilausen, and J. Hilden Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 312 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nauck, G. R. Warnick, and N. Rifai Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation Clin. Chem., February 1, 2002; 48(2): 236 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paultre, C. H. Tuck, B. Boden-Albala, D. E. Kargman, E. Todd, J. Jones, M. C. Paik, R. L. Sacco, and L. Berglund Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Warnick, M. Nauck, and N. Rifai Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays Clin. Chem., September 1, 2001; 47(9): 1579 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paultre, T. A. Pearson, H. F. C. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al. High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2619 - 2624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Benlian, C. Cansier, G. Hennache, O. Khallouf, P. Bayer, F. Duron, F. Carrat, R. Couderc, O. Chazouilleres, J. Bardet, et al. Comparison of a New Method for the Direct and Simultaneous Assessment of LDL- and HDL-Cholesterol with Ultracentrifugation and Established Methods Clin. Chem., April 1, 2000; 46(4): 493 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nauck, W. Marz, and H. Wieland Is Lipoprotein(a) Cholesterol a Significant Indicator of Cardiovascular Risk? Clin. Chem., March 1, 2000; 46(3): 436 - 437. [Full Text] [PDF] |
||||
![]() |
A. Schlenck, B. Herbeth, G. Siest, and S. Visvikis Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels J. Lipid Res., November 1, 1999; 40(11): 2125 - 2133. [Abstract] [Full Text] |
||||
![]() |
J. T. Moroney, M.-X. Tang, L. Berglund, S. Small, C. Merchant, K. Bell, Y. Stern, and R. Mayeux Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke JAMA, July 21, 1999; 282(3): 254 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugiuchi, T. Irie, Y. Uji, T. Ueno, T. Chaen, K. Uekama, and H. Okabe Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and {alpha}-cyclodextrin sulfate Clin. Chem., March 1, 1998; 44(3): 522 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Tuck, S. Holleran, and L. Berglund Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1822 - 1829. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |